141 related articles for article (PubMed ID: 9777790)
1. The pathogenesis of psoriasis and the mechanism of action of tazarotene.
Duvic M; Asano AT; Hager C; Mays S
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S129-33. PubMed ID: 9777790
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of tazarotene action in psoriasis.
Duvic M; Nagpal S; Asano AT; Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
[TBL] [Abstract][Full Text] [Related]
3. Rational design of receptor-selective retinoids.
Chandraratna RA
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S124-8. PubMed ID: 9777789
[TBL] [Abstract][Full Text] [Related]
4. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
Dando TM; Wellington K
Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety review of tazarotene.
Marks R
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene in combination with topical corticosteroids.
Lebwohl M; Poulin Y
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.
DiSepio D; Ghosn C; Eckert RL; Deucher A; Robinson N; Duvic M; Chandraratna RA; Nagpal S
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14811-5. PubMed ID: 9843971
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of biomarkers in psoriasis.
Rashmi R; Rao KS; Basavaraj KH
Clin Exp Dermatol; 2009 Aug; 34(6):658-63. PubMed ID: 19558584
[TBL] [Abstract][Full Text] [Related]
11. Tazarotene in combination with phototherapy.
Koo JY
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
[TBL] [Abstract][Full Text] [Related]
12. Topical tazarotene vs. coal tar in stable plaque psoriasis.
Kumar U; Kaur I; Dogra S; De D; Kumar B
Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
14. Tazarotene--first of a new generation of receptor-selective retinoids.
Chandraratna RA
Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
16. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis.
Sebök B; Bonnekoh B; Kerényi M; Gollnick H
Skin Pharmacol Appl Skin Physiol; 2000; 13(5):285-91. PubMed ID: 10940819
[TBL] [Abstract][Full Text] [Related]
18. Response of psoriasis to a new topical retinoid, AGN 190168.
Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M
J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
[TBL] [Abstract][Full Text] [Related]
19. The role of tazarotene in the treatment of psoriasis.
Marks R
Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD; Koo JY; Krueger GG; Lebwohl MG; Lowe NJ; Menter MA; Lew-Kaya DA; Sefton J; Gibson JR; Walker PS;
J Am Acad Dermatol; 2003 May; 48(5):760-7. PubMed ID: 12734506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
